NanosonicsNNCSF 90 EV-to-FCF is 35.05 as of Jun. 27, 2026, which is 50% below its 10-year median of 70.71. GuruFocus rates NNCSF with a GF Score™ of 90/100 and a GF Value™ of $3.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 421 Medical Devices & Instruments companies, Nanosonics ranks worse than 64.61% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nanosonics's Enterprise Value is $558.4 Mil.
Nanosonics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $15.9 Mil. Therefore, Nanosonics's EV-to-FCF for today is 35.05.
The historical rank and industry rank for Nanosonics's EV-to-FCF or its related term are showing as below:
NNCSF'
s EV-to-FCF Range Over the Past 10 Years
Min: -6145.79 Med: 70.71 Max: 869.12
Current: 33.2
During the past 13 years, the highest EV-to-FCF of Nanosonics was 869.12. The lowest was -6145.79. And the median was 70.71.
NNCSF's EV-to-FCF is ranked worse than 64.61% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs NNCSF: 33.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nanosonics's share price for today is $2.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nanosonics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.044.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nanosonics EV-to-FCF Related Terms
Nanosonics EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Nanosonics's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nanosonics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanosonics EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nanosonics's EV-to-FCF falls into.
Nanosonics's current Enterprise Value is $558.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nanosonics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $15.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanosonics (NNCSF) has a EV-to-FCF of 35.05 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nanosonics and its competitors. This is 50% below median its historical median of 70.71. According to the industry distribution chart, Nanosonics ranks #272 out of 421 companies in the Medical Devices & Instruments industry, placing it in the top 64.6%.
Is Nanosonics' EV-to-FCF too high?
Nanosonics' current EV-to-FCF of 35.05 is 50% below median its 10-year median of 70.71. The Medical Devices & Instruments industry median EV-to-FCF is 22.82. Nanosonics' value of 35.05 is 53.6% above this industry median. Based on the distribution chart, Nanosonics ranks #272 out of 421 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nanosonics has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanosonics' EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nanosonics ranks #272 out of 421 companies for EV-to-FCF. This places Nanosonics in the lower half of its industry. The industry median EV-to-FCF is 22.82. Nanosonics' value of 35.05 is 53.6% above this benchmark. While the company's 10-year median is 70.71 vs. the industry median of 22.82, Nanosonics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanosonics's current EV-to-FCF of 35.05 is 53.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nanosonics and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanosonics's current EV-to-FCF is 35.05, which is 50% below median its own 10-year median of 70.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosonics stock overvalued right now?
Based on GuruFocus' analysis, Nanosonics (NNCSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.56, compared to a current price of $2.55 — trading 28.4% below its estimated fair value. The current EV-to-FCF is 35.05, which is 50% below median its 10-year median of 70.71 and 53.6% above the Medical Devices & Instruments industry median of 22.82. Nanosonics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Nanosonics (NNCSF), the current EV-to-FCF is 35.05 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanosonics (NNCSF) Overvalued in 2026?
Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued.
The current stock price of $2.55 is trading 28.4% below its estimated GF Value™ of $3.56.
GuruFocus considers Nanosonics to be Modestly Undervalued.
Key valuation signals for NNCSF:
EV-to-FCF: 35.05 (50% below median its 10-year median of 70.71)
GF Value™: $3.56 vs. price of $2.55 (28.4% below fair value)
Industry Position: 53.6% above the Medical Devices & Instruments median (#272 of 421)
No single metric tells the full story. See the NNCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
90GF Score
Get the complete analysis for NNCSF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NNCSF has been successfully added to your 
